Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate in Friedreich Ataxia
NCT04921930Phase 2Completed
- Sponsor
- Inserm
- Start
- May 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate in Friedreich ataxia (FA), sponsored by Inserm. Started May 2022; status: completed.
02
Drugs
artesunate
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT04921930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04921930.